ArticlePsychiatric research and clinical practice2025
Are There Race-Based Differences in Neuropsychological Test Performance and Psychological Symptom Endorsement Among Adults Diagnosed With ADHD?
Article in Psychiatric research and clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Prevalence rates of attention-deficit/hyperactivity disorder (ADHD) vary by several demographic factors, including sex, socioeconomic status, geographic region, and race/ethnicity, with higher rates seen among non-Hispanic White children and adults compared to racially/ethnically minoritized individuals. This study investigated if similar race-based differences exist in neurocognitive test performance and psychiatric/ADHD symptom reporting among groups in a demographically diverse sample. Methods: Data from 491 adults with a confirmed diagnosis of ADHD were analyzed to assess for differences in broad neurocognitive domains (i.e., learning and memory, attention/working memory, processing speed, and executive functions), as well as on measures of mood and ADHD-related symptomatology. Results: Findings largely demonstrated comparable neurocognitive test performance and ADHD and psychiatric symptom endorsement across racial groups with a known diagnosis of ADHD. Conclusions: Although prior research has consistently documented racial/ethnic disparities in rates of ADHD diagnosis, current results largely did not demonstrate neuropsychological performance-based differences among demographically diverse patients diagnosed with ADHD. Relevance to clinical practice: ADHD is one of the most prevalent neurodevelopmental disorders in the U.S. and constitutes a large number of referrals for diagnostic evaluation. Despite disparities in rates of diagnosis among broad racial/ethnic groups, neuropsychological outcomes remain largely consistent among these groups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.